Navigation Links
Quarter of Disabled Seniors Use Risky Medications
Date:5/7/2008

Drugs regarded as ineffective or posing high risk of side effects, analysis finds

WEDNESDAY, May 7 (HealthDay News) -- Senior citizens with disabilities are twice as likely as their non-disabled counterparts to being taking at least one prescription drug deemed inappropriate for people 65 or older, according to new research.

The study, based on 2004 data, reports that about a quarter of disabled seniors in the United States have taken one of 33 medications regarded as ineffective or posing a high risk of side effects to the elderly. These drugs include Xanax, Demerol, Darvon and Procardia.

Only 13 percent of seniors without disabilities used these medications, according to the analysis, published in the latest News and Numbers from the U.S. Agency for Healthcare Research and Quality.

The analysis also found the prescription drug misuse ran slightly higher among people with complex disabilities when compared with those having basic disabilities (27 percent vs. 23 percent). A person is considered to have a complex disability if his or her ability to work or socialize is hindered; a person with only limited ability to walk, bathe or perform everyday activities is said to have a basic disability.

Education, but neither race nor ethnicity, appeared to affect the likelihood that seniors would take an inappropriate medication. Disabled seniors with disabilities who did not finish or receive education beyond high school were more likely to use potentially inappropriate drugs than those who attended college.

The analysis is based on the 2007 National Healthcare Disparities Report, an examination of disparities in access to and quality of health care by race, ethnicity, income and education.

More information

The U.S. Food and Drug Administration has more about medications and older people.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Weight Watchers Declares Quarterly Dividend
3. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
4. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
5. Medical Services International Maintains Pace in Second Quarter
6. Martek Announces Third Quarter 2007 Financial Results
7. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
8. MDS Reports Third Quarter 2007 Results
9. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
10. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RNewswire/ -- HealthPlus of Michigan today announc... plans designed for Medicare-eligible people looki...ccess to quality health care. ,, HealthPlus Me... in Michigan, according to the "America,s Best Hea... & World Report and the National Committee on ...
(Date:11/30/2009)...or Alonzo L. Fulgham ,, WASHINGTON, Nov. 30 /P...al community once again recognizes World AIDS Day ...ldwide. This is also a time to renew our commitme... and pay homage to the millions of people who have...er in the U.S. President,s Emergency Plan for AIDS...
(Date:11/30/2009)...ewswire/ -- Major League Baseball,s Mark Teahen,... and recently acquired by the Chicago White Sox, w...d is given annually to a Major League Baseball pla...dication of baseball great Fred Hutchinson, both o...ands, Calif., native made his MLB debut with the R...
(Date:11/30/2009)...ent for blood-borne diseases, researchers say , ... medical students get stuck by needles, putting th...n fail to alert hospital authorities, which increa.... , The researchers interviewed 699 surgery res... 59 percent -- had experienced needlestick injurie...
(Date:11/30/2009)...RNewswire-USNewswire/ -- SEIU Local 21LA members a... Sodexo will hold a rally Tuesday, Dec. 1, 2009, a...arters, 3800 Desire Parkway, New Orleans, to prote...iplinary policies that target employees who are il...dexo employees who clean schools in the Recovery S...
Breaking Medicine News(10 mins):Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:USAID Recognizes World AIDS Day 2Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2
...hat doing household activities like cleaning the h...prevent hypertension and conditions of prehyperten...rdless of intensity, four hours of accumulated dai... from prehypertensive to normal -- for an average ...
...Electric (GE), Tuesday launched HF Advantage, the ...nd made in India for the domestic and internationa...technology, the state-of-the-art product is equipp...rs at the John F. Welch Technology Centre of GE in...
...a new cheaper tissue culture vaccine for Japanese ...reported 200 deaths and 700 patients with infectio...y year due to the endemic infection of Encephaliti...4 hours, in which 12 persons died. The health ...
... of Wisconsin-Madison had reported that specific b...re affected by stress, like asthma. The study...oceedings of the National Academy of Sciences, // ...ggest potential future targets for the development...
...i may soon become part of the Indian government's ...to spread awareness about HIV/AIDS and promote the...rts have failed in reaching supplies of condoms, t... country. It has been proposed to advertise...
...ovarian cancer, according to a new Danish study, w...sk of some other forms of cancer. Women who ex...uction in the risk of development of ovarian cance...ercise habits of nearly 28,000 men and women, has ...
Other Medicine News:Health News:New X-ray machine launched by GE Healthcare 2
(Date:11/30/2009)... N.J., Nov. 30 MedQuist ...ology-enabled clinical documentation services, tod...Nuance Communications, Inc. (Nuance) under which M...ch recognition engine and processing software for ... front-end speech recognition application for all ...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...
(Date:11/30/2009).... 30 Dr. Jocelyn Rapelyea, Associa...George Washington University Medical Center in Was...ntified with Breast-Specific Gamma Imaging (BSGI) ...for needle biopsy as well, as for pre-operative lo...ological Society of North America (RSNA). ,, BS...
Breaking Medicine Technology:MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 1Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 2Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 3Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4
...Reported Safety & Tolerability Profile,in Subj... CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- ...eeting of the American Diabetes,Association demons...l-peptidase-4 (DPP-4) in development by Bristol-My...n with metformin,exhibited a statistically signif...
...NYVALE, Calif., June 27, 2007,/PRNewswire-FirstCal...ary results from two open-label, multi-center Phas...f Xcytrin(R),(motexafin gadolinium) Injection, the...with Alimta(R) (pemetrexed) and in,combination wit...nt,for patients with non-small cell lung cancer (N...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5
VISCO SHIELD Viscoelastic
Universal I/A handpiece - Stainless steel (Round Handle with Straight Tip)
Infusion Cannula 4.0mm
Subretinal Fluid Cannula Curved
Medicine Products: